Kevin C Conlon, M.D.
National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kevin C Conlon, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:31 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06865677 · Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical CarcinomasNational Cancer Institute (NCI) · terminated · Recurrent Platinum Resistant Epithelial Ovarian Carcinoma, Recurrent Epithelial Endometrial Carcinoma, Recurrent Epithelial Cervical Carcinoma · principal investigator
- Ph1NCT04639843 · Doxorubicin, CC-(486) (5-azacitidine), Romidepsin, and Duvelisib (hARD) for T-cell LymphomaNational Cancer Institute (NCI) · withdrawn · Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma · principal investigator
- Ph2NCT04150562 · Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal CarcinomaNational Cancer Institute (NCI) · terminated · Clear-Cell Renal Carcinoma · principal investigator
- Ph1NCT03905135 · Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell MalignanciesNational Cancer Institute (NCI) · completed · Peripheral T-cell Lymphoma NOS, Mycosis Fungoides, Sezary Syndrome · principal investigator
- Ph1NCT03759184 · Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte LeukemiaNational Cancer Institute (NCI) · terminated · Leukemia, Lymphocytic, Chronic · principal investigator
- N/ANCT03189108 · Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid TumorsNational Cancer Institute (NCI) · terminated · Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer · principal investigator
- Ph1/Ph2NCT01712659 · Ruxolitinib for Adult T-Cell LeukemiaNational Cancer Institute (NCI) · terminated · T Cell Leukemia, Adult, Leukemia, Adult T-Cell, T Cell Leukemia, HTLV I Associated · principal investigator
- Ph1NCT01572493 · Continuous Infusion of rhIL-15 for Adults With Advanced CancerNational Cancer Institute (NCI) · completed · Lymphoma, Carcinoma · principal investigator
- Ph1/Ph2NCT01468311 · Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's LymphomaNational Cancer Institute (NCI) · terminated · Hodgkin Disease, Hodgkin Lymphoma · principal investigator
- N/ANCT00001582 · Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and CancerNational Cancer Institute (NCI) · completed · T-cell Lymphoma, B-Cell Lymphoma, ATL · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.